Möchten Sie immer auf dem neuesten Stand bleiben?

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best? Semaglutide and Tirzepatide Compared. Confused about GLP-1 options for weight management? Take...

Austin, TX, USA, June 17, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “GLP-1 Receptor Agonist Market Size, Trends and Insights By Product Type...

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com announces the release of its comprehensive Medvi Review, focusing on telehealth GLP-1 programs for weight management. Considering GLP-1...

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including...

Featured in The Wall Street Journal, Impact Analytics’ report warns GLP-1 adoption could put over $5B in retail sales at risk.

TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- GLP North, a Canadian supplier focused on ready-to-use research pen formats, has added Retaject availability to its Canadian research catalogue. The...

Arlington, VA, June 01, 2026 (GLOBE NEWSWIRE) -- New online community brings together people navigating GLP-1 medications, diabetes, obesity, metabolic health, and related conditions to learn,...

Kailera will present at the 2026 Jefferies Global Healthcare Conference on Thursday, June 4, at 10:30 am EDT.

Serotonin Centers opens new Lake Nona longevity center offering physician-led wellness, diagnostics, hormone optimization and recovery therapies.